Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,838 | 22 | 95.3% |
| Gift | $90.00 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,602 | 20 | $0 (2020) |
| Orexo US, Inc. | $120.90 | 1 | $0 (2019) |
| US WorldMeds, LLC | $115.47 | 1 | $0 (2018) |
| Sekisui Diagnostics, LLC | $90.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $90.00 | 1 | Sekisui Diagnostics, LLC ($90.00) |
| 2020 | $207.57 | 2 | GlaxoSmithKline, LLC. ($207.57) |
| 2019 | $799.33 | 9 | GlaxoSmithKline, LLC. ($678.43) |
| 2018 | $402.27 | 4 | GlaxoSmithKline, LLC. ($286.80) |
| 2017 | $428.92 | 7 | GlaxoSmithKline, LLC. ($428.92) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/01/2022 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $90.00 | General |
| 02/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $110.29 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $97.28 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $102.94 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2019 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $120.90 | General |
| Category: Addiction Medicine | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $118.51 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $88.74 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $123.40 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $119.48 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $93.64 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $122.85 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2018 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $115.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/25/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $100.55 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $63.40 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $99.41 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $70.86 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $99.64 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $106.62 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 44 | $7,480 | $2,682 |
| 2022 | 2 | 44 | 245 | $41,860 | $24,183 |
| 2021 | 2 | 45 | 219 | $36,100 | $21,112 |
| 2020 | 2 | 43 | 217 | $34,150 | $17,066 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 44 | $7,480 | $2,682 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 221 | $35,860 | $21,218 | 59.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 24 | $6,000 | $2,965 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 198 | $30,850 | $18,342 | 59.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 21 | $5,250 | $2,770 | 52.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 201 | $30,150 | $15,672 | 52.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $4,000 | $1,394 | 34.9% |
About Dr. John Machata, MD
Dr. John Machata, MD is a Family Medicine healthcare provider based in North Kingstown, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922064534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Machata, MD has received a total of $1,928 in payments from pharmaceutical and medical device companies, with $90.00 received in 2022. These payments were reported across 23 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,838).
As a Medicare-enrolled provider, Machata has provided services to 151 Medicare beneficiaries, totaling 725 services with total Medicare billing of $65,043. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location North Kingstown, RI
- Active Since 04/22/2006
- Last Updated 09/05/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922064534
Products in Payments
- TRELEGY ELLIPTA (Drug) $939.11
- NUCALA (Biological) $233.69
- ANORO ELLIPTA (Drug) $206.03
- INCRUSE (Drug) $170.50
- Zubsolv (Drug) $120.90
- Lucemyra/Lofexidine (Drug) $115.47
- ANORO (Drug) $52.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.